|
RESEARCH OBJECTIVES
The object of these programs is to provide support for
projects that will further the research and development
of effective vaccines and related technologies for cancer.
It is recognized that research of various stages, from
basic to applied, can contribute to a better understanding
of vaccine development and use. Highly innovative proposals,
both solicited and unsolicited, are welcome.
Topics for grant applications
may include, but are not limited to, innovations
in cancer vaccines covering:
-
Vaccine adjuvants
-
Vaccine efficacy assessment
-
Target selection
-
Vaccine approaches
-
Animal models for testing vaccines
-
Clinical assessment of vaccines
-
Diagnostic techniques
Topics and approaches are limited only by the
imagination of the scientist and their institution,
but attention must focus on achieving a specific
goal.
ELIGIBLE
APPLICANTS
Investigators at public and private, nonprofit or for-profit
institutions, in the cancer and related scientific community
or outside, and anywhere in the world, are invited to
apply for funds. The grants will be awarded to the investigatorsf
institutions, once agreements to oversee the financial
and ethical aspects of the research are defined. All
work and activity must comply with the laws of the country
in which the work will be done as well as the policy
of HIRF. Specifically, the costs of administration or
other indirect expenses can also be requested, if necessary,
but will be limited to a maximum of twenty (20) % of
the direct costs.
GENERAL
REVIEW PROCESS AND CRITERIA
In general, applications will be reviewed in a two-stage
process:
| First: |
An initial review for scientific
merit will be carried out by scientist(s) representing
one or more relevant scientific areas. |
| Second: |
A second review by advisors of the
HIRF will consider the comments of initial reviewers,
programmatic balance, and availability of funds
in making a final decision. |
All reviewers will agree to confidentially in advance
of receipt of applications.
The Scientific Merit review will focus on three criteria
for assessing the proposals, as follows:
- A) Scientific relevance
B) Soundness of the scientific approach and methods
C) Innovation
APPLICATION FORMS AND INSTRUCTIONS
A complete application must contain the following components:
-
Cover Sheet (1 page):
Page 1 of the application should be a cover sheet
or face page giving a descriptive title of the project,
the name and full contact information (phone, fax,
email and mailing address) of the principle investigator
who will assume responsibility for the scientific
conduct of the research, the name and address of
the institution that would administer the grant,
the name and full contact information of an officer
of the institution empowered to enter into grant
contracts, and the names of all collaborating scientists
and institutions.
-
Abstract (1/2-page):
In addition to the description of the research plan,
an abstract of the research proposed, on a separate
page and limited to one-half page of text.
-
Budget (up to 5 pages):
A budget and budget description should be included,
itemizing the U.S. dollar amounts requested for
salaries, supplies, equipment, travel and any other
expenses required for the conduct of the research.
It is expected that the funds will be defined by
year. A narrative explanation of how requested budget
items will contribute to the conduct of the research
is required. In addition to the direct costs, institutions
may request funds for the grant administration or
other indirect expenses, if necessary, but these
are limited by HIRF policy to twenty (20) % of the
direct costs.
-
Research Plan (not limited):
The description of the research plan is
not limited. No specific format is required for
presenting the research plan, but applicants are
urged to present the aims of the project clearly,
and to provide the reviewers with sufficient information
to assess the proposal with regard to these criteria
for review.
-
PI, Key Scientist and Technical Personnel
(up to 3 pages) :
Brief biographical sketches for all key scientists
and technicians involved in the research are requested.
No specific format is required, but the biosketches
are limited to three pages for each investigator.
SUBMISSION PROCEDURE
Three paper copies (including copies of Appendix, if
submitted) and one electronic copy of the full application
are to be submitted. The paper copies of the application
should be sent via gFedExh or gUPSh to HIRF at the following
address:
Hasumi International Research Foundation
Attn: Minoru Komura, Managing Director
2300 M Street, Suite 800, NW, Washington, DC 20037
USA
Tel: 202-973-6459
|